PASSARIELLO, MARGHERITA
 Distribuzione geografica
Continente #
NA - Nord America 331
EU - Europa 225
AS - Asia 48
AF - Africa 16
SA - Sud America 2
OC - Oceania 1
Totale 623
Nazione #
US - Stati Uniti d'America 329
IT - Italia 157
NL - Olanda 47
CN - Cina 26
IN - India 20
CI - Costa d'Avorio 15
SE - Svezia 5
IE - Irlanda 4
FI - Finlandia 3
GB - Regno Unito 3
BR - Brasile 2
DE - Germania 2
AU - Australia 1
CA - Canada 1
ES - Italia 1
FR - Francia 1
LA - Repubblica Popolare Democratica del Laos 1
PA - Panama 1
RS - Serbia 1
SG - Singapore 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 623
Città #
Chandler 78
Naples 70
Amsterdam 47
Ashburn 45
Napoli 24
Pune 18
Lawrence 17
Beijing 16
Boston 16
Des Moines 10
Millbury 10
Acerra 5
Seattle 5
Wilmington 5
Marano di Napoli 4
Nanjing 4
Trentola-Ducenta 3
Bernalda 2
Casavatore 2
Dublin 2
Houston 2
Indore 2
Ischia 2
Kronberg 2
Lappeenranta 2
Marano 2
Marcianise 2
Princeton 2
Quartu Sant'elena 2
Shanghai 2
São Paulo 2
Aprilia 1
Augusta 1
Belgrade 1
Fairfield 1
Formia 1
Guangzhou 1
Hebei 1
Jiaxing 1
Los Angeles 1
Milan 1
Misterbianco 1
Mugnano di Napoli 1
Nola 1
Norwalk 1
Panama City 1
Pinerolo 1
Pozzuoli 1
San Giorgio a Cremano 1
Silea 1
Sydney 1
Vientiane 1
Washington 1
Winnipeg 1
Wynberg 1
Totale 429
Nome #
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 38
Long-chain polyphosphates impair SARS-CoV-2 infection and replication 38
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies. 37
Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries 37
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2 36
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells 34
A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells 33
Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells. 33
Novel Human Bispecific Aptamer-Antibody Conjugates for Efficient Cancer Cell Killing 31
Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab 30
Interactions of spike‐rbd of sars‐cov‐2 and platelet factor 4: New insights in the etiopathogenesis of thrombosis 30
Evaluation of the antiproliferative effect of Bifidobacterium longum BB-536 in solid tumor cell lines, co-cultured with murine splenocytes 30
Novel combinations of human immunomodulatory mAbs lacking cardiotoxic effects for therapy of TNBC 30
T-cell Activating Tribodies as a Novel Approach for Efficient Killing of ErbB2-positive Cancer Cells. 26
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab 25
Superior Suppression of ErbB2-positive Tumor Cells by a Novel Human Triparatopic Tribody 24
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model 23
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand 23
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling 22
Evidences of CTLA-4 and PD-1 blocking agents-induced cardiotoxicity in cellular and preclinical models 18
Immunomodulatory mabs as tools to investigate on cis-interaction of pd-1/pd-l1 on tumor cells and to set up methods for early screening of safe and potent combinatorial treatments 18
Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivo 17
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC 16
Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy 11
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways 11
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays 8
A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies 4
Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology 4
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma 2
Totale 689
Categoria #
all - tutte 2.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.957


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/202041 7 0 1 4 7 0 0 2 3 10 6 1
2020/202148 0 0 12 1 0 1 0 4 0 19 11 0
2021/2022145 0 4 1 1 1 4 16 9 10 21 41 37
2022/2023241 19 12 9 13 29 25 0 24 37 46 23 4
2023/2024194 10 28 52 21 9 39 10 25 0 0 0 0
Totale 689